GBA1 and Parkinson disease: Background and Aims: The aim of this study was to investigate the impact of the beta glucocerebrosidase (GBA) gene mutation on quality of life (QoL) and activities of daily living (ADL) in patients with idiopathic Parkinson's disease (PD).